Eagle Asset Management Inc Amphastar Pharmaceuticals, Inc. Transaction History

Eagle Asset Management Inc

$16.7 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	SELL	$44.49 - $62.93 $73,808 - $104,400	-1,659 Reduced 4.4%	36,042 $2.23 Million
Q3 2023 Nov 13, 2023	SELL	$45.51 - $65.0 $1.45 Million - $2.07 Million	-31,888 Reduced 45.82%	37,701 $1.73 Million
Q2 2023 Aug 09, 2023	SELL	$35.77 - $58.38 $8.48 Million - $13.8 Million	-237,181 Reduced 77.32%	69,589 $4 Million
Q1 2023 May 08, 2023	BUY	$27.99 - $37.92 $165,057 - $223,614	5,897 Added 1.96%	306,770 $11.5 Million
Q4 2022 Feb 14, 2023	SELL	$27.93 - $31.27 $262,039 - $293,375	-9,382 Reduced 3.02%	300,873 $8.43 Million
Q3 2022 Nov 07, 2022	BUY	$27.56 - $37.75 $2.28 Million - $3.13 Million	82,796 Added 36.4%	310,255 $8.72 Million
Q2 2022 Aug 10, 2022	BUY	$29.79 - $42.29 $1.49 Million - $2.12 Million	50,120 Added 28.26%	227,459 $7.91 Million
Q1 2022 May 12, 2022	SELL	$22.96 - $36.45 $1.71 Million - $2.71 Million	-74,277 Reduced 29.52%	177,339 $6.37 Million
Q4 2021 Feb 11, 2022	SELL	$18.14 - $23.29 $598,656 - $768,616	-33,002 Reduced 11.6%	251,616 $5.82 Million
Q3 2021 Nov 10, 2021	SELL	$17.83 - $21.49 $354,032 - $426,705	-19,856 Reduced 6.52%	284,618 $5.41 Million
Q2 2021 Aug 11, 2021	SELL	$17.11 - $20.92 $102,403 - $125,206	-5,985 Reduced 1.93%	304,474 $6.14 Million
Q1 2021 May 14, 2021	SELL	$17.21 - $20.65 $33,800 - $40,556	-1,964 Reduced 0.63%	310,459 $5.62 Million
Q4 2020 Feb 12, 2021	BUY	$17.76 - $21.24 $500,459 - $598,521	28,179 Added 9.91%	312,423 $6.28 Million
Q3 2020 Nov 12, 2020	SELL	$17.99 - $22.22 $305,362 - $377,162	-16,974 Reduced 5.64%	284,244 $5.3 Million
Q2 2020 Aug 12, 2020	SELL	$14.25 - $22.46 $238,972 - $376,654	-16,770 Reduced 5.27%	301,218 $6.66 Million
Q1 2020 May 11, 2020	BUY	$12.66 - $20.08 $427,300 - $677,740	33,752 Added 11.87%	317,988 $4.72 Million
Q4 2019 Feb 07, 2020	BUY	$17.07 - $20.64 $4.85 Million - $5.87 Million	284,236 New	284,236 $5.48 Million

Others Institutions Holding AMPH

# of Institutions

280

Shares Held

36.7M

Call Options Held

74.3K

Put Options Held

22.3K

View Full List

About Amphastar Pharmaceuticals, Inc.

Ticker AMPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,015,200
Market Cap $1.64B
Description
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...

More about AMPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eagle Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Eagle Asset Management Inc with notifications on news.

Account